Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Kezar Life Sciences, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q2 2025
- Shares held
- 4.24M
- −235.2K (−5.3%) vs. Q2 2025
- Total value
- $16.5M
- −$3.96M (−19.3%) vs. Q2 2025
- New holders
- 3
- 9 more added
- Sold out
- 4
- 8 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 51 | $199 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 90 | $323 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 96 | $374 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 100 | $390 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 121 | $472 | 0.00% | −59−32.8% | Reduced |
| JPMorgan Chase & Co | 209 | $815 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 356 | $1.39K | 0.00% | +315+768.3% | Added |
| Global Retirement Partners, LLC | 1,000 | $3.90K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,187 | $4.63K | 0.00% | +1,042+718.6% | Added |
| Wells Fargo & Company | 5,846 | $22.8K | 0.00% | +100+1.7% | Added |
| Morgan Stanley | 7,820 | $30.5K | 0.00% | −873−10.0% | Reduced |
| FMR LLC | 8,732 | $34.1K | 0.00% | −13,933−61.5% | Reduced |
| Landscape Capital Management, L.L.C. | 13,042 | $50.9K | 0.00% | +13,042 | New |
| Northern Trust Corp | 13,940 | $54.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,221 | $71.1K | 0.00% | +18,221 | New |
| Boothbay Fund Management, LLC | 20,900 | $81.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,093 | $82.3K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 23,231 | $90.6K | 0.00% | −6,739−22.5% | Reduced |
| Two Sigma Investments, LP | 23,682 | $92.4K | 0.00% | −1,201−4.8% | Reduced |
| RBF Capital, LLC | 28,253 | $110.2K | 0.01% | 00.0% | Unchanged |
| Bluefin Capital Management, LLC | 33,610 | $131.1K | 0.06% | +33,610 | New |
| Bridgeway Capital Management, LLC | 41,000 | $159.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 54,261 | $211.6K | 0.00% | −380−0.7% | Reduced |
| Geode Capital Management, LLC | 65,502 | $255.5K | 0.00% | +383+0.6% | Added |
| Shay Capital LLC | 67,661 | $263.9K | 0.05% | 00.0% | Unchanged |
| Qiming U.S. Ventures Management, LLC | 82,871 | $323.2K | 0.58% | 00.0% | Unchanged |
| BlackRock, Inc. | 98,103 | $382.6K | 0.00% | +432+0.4% | Added |
| Ikarian Capital, LLC | 106,901 | $416.9K | 0.09% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 115,885 | $452.0K | 0.00% | +28,601+32.8% | Added |
| ADAR1 Capital Management, LLC | 124,967 | $487.4K | 0.05% | −22,437−15.2% | Reduced |
| Peapod Lane Capital LLC | 125,773 | $490.5K | 0.44% | +10,650+9.3% | Added |
| Acadian Asset Management LLC | 133,525 | $519.0K | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 192,700 | $751.5K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 268,166 | $1.05M | 0.00% | −8,062−2.9% | Reduced |
| Stonepine Capital Management, LLC | 383,182 | $1.49M | 1.21% | +213,323+125.6% | Added |
| Suvretta Capital Management, LLC | 716,759 | $2.80M | 0.08% | 00.0% | Unchanged |
| Tang Capital Management LLC | 720,000 | $2.81M | 0.11% | 00.0% | Unchanged |
| BML Capital Management, LLC | 720,787 | $2.81M | 2.59% | +85,604+13.5% | Added |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −502,600−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −58,539−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,677−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |